LPL Financial
LPLA
$318.85
-0.68%
LPL Financial Holdings is the largest independent broker/dealer in the United States, providing turnkey wealth management infrastructure, advisory platforms, custody, recordkeeping, and technology services to more than 32,000 affiliated financial advisors overseeing roughly $2.4 trillion in client assets across approximately 11 million accounts. Its competitive identity rests on scale and affiliation flexibility — spanning traditional independent advisor models to pure RIA custody — which makes it the industry's principal consolidator of advisor talent and a structural share gainer as wirehouse advisors migrate to independence. The current investor debate centers on the durability of cash sweep revenue, which management has been deliberately repricing lower to share rate benefits with advisors, against the offsetting tailwind of record recruiting, asset growth, and acquisition-driven expansion (the Q3 2025 cash flow statement shows roughly $1.54 billion of acquisitions). Recent quarterly results showed revenue growth reaccelerating sharply, but a negative free cash flow TTM figure and a stock that has lagged the S&P 500 by roughly 19 percentage points over the past year keep the narrative contested between margin-compression bears and asset-gathering bulls.…
LPLA
LPL Financial
$318.85
Related headlines
Investment Opinion: Should I buy LPLA Today?
Rating: Hold with a bullish bias. The core thesis is that LPLA's 35.24% revenue growth and 10.63x forward PE offer an attractive risk/reward, but negative TTM free cash flow of -$1.05 billion and unresolved sweep-revenue repricing justify waiting for confirmation. The analyst consensus of Buy (mean 1.72) with an average target of $422.38 implies 31.6% upside, anchoring the constructive view.
Supporting evidence is mixed but leans positive on valuation: PS of 1.65x and EV/Sales of 1.60x are far below the stock's historical PS band of roughly 4.3x–8.1x, while revenue grew 35.24% YoY in Q2 2026 and gross margin improved to 31.38% from 25.23% in Q1 2026. ROE of 16.15% and a current ratio of 2.42 with $2.93 billion of cash provide a solid balance-sheet cushion, and the forward PE of 10.63x versus trailing 32.56x implies the market expects a major earnings step-up. The main offset is that trailing free cash flow is negative and the stock has lagged the S&P 500 by 19.27 percentage points over one year.
Key risks that could invalidate the thesis are a permanent sweep-revenue reset that keeps operating margins below 13.45%, a failure to convert revenue growth into positive free cash flow, and further acquisition integration charges like the $219 million Q3 2025 expense. The rating would upgrade to Buy if TTM free cash flow turns positive and operating margin recovers above 15%, or downgrade to Sell if revenue growth decelerates below 20% or the stock breaks below $302 support. On balance, the stock looks undervalued on sales and forward earnings but fairly valued on trailing earnings, so the verdict is fairly valued with upside optionality rather than a clear bargain.
Sign up to view all
LPLA 12-Month Price Forecast
The forward-looking view is balanced: revenue momentum and a low forward PE argue for upside, but negative free cash flow and unresolved sweep repricing cap conviction. The base case (50% probability) targets $354–$422, consistent with the analyst low-to-average range, while the bull case (30%) reaches $422–$554 if margins recover. The bear case (20%) targets $260–$302, anchored on the 52-week low and the $302 support shelf. I would upgrade to bullish if Q3 2026 shows positive free cash flow and operating margin above 15%, and downgrade to bearish if revenue growth falls below 20% or the stock breaks $302.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on LPL Financial's 12-month outlook, with a consensus price target around $422.38 and implied upside of +32.5% versus the current price.
Average Target
$422.38
0 analysts
Implied Upside
+32.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$354 - $554
Analyst target range
Coverage is robust with 16 analysts and a consensus recommendation of Buy (mean rating 1.72 on a 1-to-5 scale), and the average target price of $422.38 implies roughly 31.6% upside from the current $320.96 — a decidedly bullish consensus stance that stands in sharp contrast to the stock's -3.74% one-year performance. The bullish tilt is corroborated by recent actions: UBS upgraded to Buy from Neutral in April 2026, Keefe Bruyette maintained Outperform, and JP Morgan and Morgan Stanley carry Overweight ratings, while the notable bear is Citigroup, which moved to Sell in July 2025.
The target range of $354 to $554 is wide — a 56% spread from low to high — signaling genuine disagreement about the earnings trajectory. The $554 high target likely assumes successful sweep-revenue stabilization, continued 30%+ revenue growth, and multiple expansion toward the forward PE's implied earnings power, while the $354 low (still 10% above the current price) prices in margin compression and integration drag but no catastrophic scenario. The absence of any target below the current price is itself a signal of conviction, though the dispersion suggests investors should expect continued volatility until the next earnings print clarifies the margin and cash flow trajectory.
Bulls vs Bears: LPLA Investment Factors
The bear case currently has stronger near-term evidence: negative TTM free cash flow of -$1.05 billion, margin compression from sweep repricing, and a 19-point relative underperformance versus the S&P 500 are concrete and recent. The bull case rests on forward-looking data — 35% revenue growth, a 10.6x forward PE, and a $422 average analyst target — that has not yet been validated by cash flow or margin recovery. The single most important tension is whether the sweep-revenue repricing is a temporary investment in advisor retention or a structural margin reset; if margins normalize toward the 2022–2023 high-teens operating level, the forward PE of 10.6x makes the stock deeply undervalued, but if repricing proves permanent, trailing earnings power is overstated and the 32.6x trailing PE is justified. Until the next earnings print clarifies the margin and cash flow trajectory, the stock is likely to remain range-bound between $302 support and $377 resistance.
Bullish
- Revenue accelerating at 35% YoY: Q2 2026 revenue of $5.19 billion grew 35.24% year-over-year versus $3.84 billion in Q2 2025, and rose sequentially from $4.94 billion in Q1 2026. This is the fastest growth in the dataset and confirms that advisor recruiting and asset gathering are compounding despite sweep repricing.
- Analyst consensus targets 31.6% upside: 16 analysts carry a mean rating of 1.72 (Buy) with an average target of $422.38, implying 31.6% upside from $320.96. The lowest target of $354 is still 10% above the current price, and recent actions include a UBS upgrade to Buy in April 2026 and Overweight ratings from JPMorgan and Morgan Stanley.
- Forward PE of 10.6x implies earnings step-up: The forward PE of 10.63x versus trailing 32.56x reflects consensus EPS of $42.18 versus the current trailing figure, a 67% compression. If the forward estimate is achieved, the stock trades at a deep discount to its own historical PE range of 11.8x–27.4x.
- Sales multiple far below history: At 1.65x PS and 1.60x EV/Sales, LPLA trades well below its own multi-year PS band of roughly 4.3x–8.1x, despite 35% revenue growth. This suggests the market is pricing in margin compression that may prove temporary rather than structural.
Bearish
- Negative trailing free cash flow: TTM free cash flow is -$1.05 billion, driven by a Q3 2025 operating cash outflow of -$1.73 billion tied to working capital and acquisition funding. The negative PCF ratio of -66.43 reflects this cash burn and raises execution risk if credit markets tighten.
- Margin compression from sweep repricing: Net margin is 5.08% and operating margin 13.45%, both well below the 2022–2023 high-teens operating margins. Sweep revenue of $484.8 million is still the largest profit lever, and management's deliberate repricing to share rate benefits with advisors continues to pressure profitability.
- Earnings volatility from acquisition charges: Q3 2025 posted a net loss of -$29.5 million (-0.65% net margin) due to a $219 million other-expense charge, and Q2 2026 included $282.5 million of net other expenses. Integration costs from roughly $1.54 billion of acquisitions can swing quarterly results and obscure underlying trends.
- Leverage and capital intensity: Debt-to-equity stands at 1.36x with total debt to capitalization near 56–58%, and interest expense was $101.5 million in Q2 2026. Funding growth through external financing adds sensitivity to credit conditions and limits financial flexibility.
LPLA Technical Analysis
LPLA is in a range-bound consolidation with a modestly negative bias rather than a clean trend: the stock is down 3.74% over the past year and 11.25% year-to-date, and at $320.96 it sits at roughly 43.5% of its 52-week range of $260.15 to $400.16 — squarely in the lower-middle of the band, neither a momentum leader nor a washed-out falling knife. The 32.39% maximum drawdown underscores that this has been a volatile sideways-to-down tape, with the stock having failed repeatedly in the $370–$377 zone (August highs) and bounced off the $260s in late May. Positioning here implies the market is waiting for a catalyst rather than pricing in either euphoria or capitulation.
Short-term momentum is decelerating and diverging negatively from an already weak long-term trend: the 1-month change of -3.63% and 3-month change of -1.21% both lag the S&P 500's +1.22% and +2.69% over the same windows, producing relative strength readings of -4.85 (1-month) and -3.90 (3-month). The 6-month change of +1.12% is the lone positive data point, confirming the stock rallied into August before rolling over — a classic failed breakout pattern. The most recent session dropped 2.01% on volume of roughly 788,000 shares, and the September 22 gap lower (from $332.26 to $307.50) remains an overhead supply zone that has capped every rally attempt since.
Key technical levels are well defined: support sits at the $302–$308 shelf established in late September, with the 52-week low of $260.15 as the line in the sand, while resistance is the $370–$377 August double-top, followed by the $400.16 52-week high. A breakout above $377 would signal a resumption of the primary uptrend and likely require a fundamental catalyst such as a sweep-revenue inflection, whereas a breakdown below $302 would target the $260 low and confirm the year-long downtrend. With a beta of just 0.538, LPLA is roughly 46% less volatile than the market — a defensive characteristic that argues for larger position sizing tolerance but also explains why it has captured little of the index's upside during risk-on phases.
Beta
0.54
0.54x market volatility
Max Drawdown
-32.4%
Largest decline past year
52-Week Range
$260-$400
Price range past year
Annual Return
-6.0%
Cumulative gain past year
| Period | LPLA Return | S&P 500 |
|---|---|---|
| 1m | +3.7% | -1.2% |
| 3m | -3.0% | +3.4% |
| 6m | -0.5% | +7.0% |
| 1y | -6.0% | +14.4% |
| ytd | -11.8% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LPLA Fundamental Analysis
Revenue is growing robustly and, importantly, accelerating: Q2 2026 revenue of $5.19 billion rose 35.24% year-over-year versus $3.84 billion in Q2 2025, building on sequential progression from $4.94 billion in Q1 2026 and $4.93 billion in Q4 2025. The growth is broad-based across the disclosed segment mix — money market cash sweep revenue of $484.8 million, asset-based revenue of $265.7 million, recordkeeping of $61.3 million, and sponsorship programs of $56.7 million — with sweep economics still the single largest profit lever despite deliberate repricing. The trajectory implies the investment case is intact at the top line: advisor recruiting and asset gathering are compounding, and consensus revenue of roughly $20.7 billion for the forward year implies continued double-digit expansion.
Profitability is solid but margin direction is mixed: Q2 2026 net income was $379.3 million on a 7.31% net margin, with gross margin of 31.38% and operating margin of 15.39% — both improved versus Q1 2026's 25.23% gross and 13.08% operating margins, and versus Q4 2025's 23.69% and 11.80%. However, the Q3 2025 quarter posted a net loss of -$29.5 million (-0.65% net margin) driven by a $219 million other-expense charge, a reminder that acquisition and integration costs can swing results. The current 5.08% net margin and 13.45% operating margin sit below the 2022–2023 era's high-teens operating margins, consistent with the sweep repricing headwind and elevated D&A from deal activity.
Balance sheet and cash flow are the pressure point: debt-to-equity stands at 1.36x with total debt to capitalization near 56–58%, and trailing free cash flow is negative at -$1.05 billion, driven by the Q3 2025 operating cash outflow of -$1.73 billion tied to working capital and acquisition funding. Liquidity is nonetheless strong with a current ratio of 2.42 and $2.93 billion of cash at Q2 2026, and ROE of 16.15% and ROA of 5.40% remain respectable for a capital-markets intermediary. The company is funding growth through a mix of internal cash generation (Q2 2026 operating cash flow of $391.9 million, FCF of $192.5 million) and external financing, which raises execution risk if credit markets tighten.
Quarterly Revenue
$5.2B
2026-06
Revenue YoY Growth
+35.2%
YoY Comparison
Gross Margin
31.4%
Latest Quarter
Free Cash Flow
$-1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LPLA Overvalued?
Because LPLA is profitable (Q2 2026 net income of $379.3 million), the PE ratio is the appropriate primary metric: the trailing PE of 32.56x compares to a forward PE of just 10.63x, an extraordinary 67% compression that reflects the market's expectation of a dramatic earnings step-up — consistent with consensus EPS of roughly $42.18 versus the current trailing figure. That gap is unusually wide and warrants scrutiny; it implies either a major margin normalization or that trailing earnings are depressed by transient items, and investors should treat the forward multiple as an optimistic scenario rather than a base case.
On peer comparison, the stock trades at a PS ratio of 1.65x and EV/Sales of 1.60x, with EV/EBITDA at 15.72x and P/B at 5.26x — a premium book multiple typical of asset-light, high-ROE broker-dealer platforms, though the 1.65x sales multiple is modest for a business growing revenue 35% year-over-year. The PEG ratio of -1.44 is not meaningful given the earnings distortion, and the negative PCF ratio of -66.43 reflects the trailing FCF deficit rather than a valuation signal. Relative to capital-markets peers, the sales multiple looks undemanding while the book multiple looks full, suggesting the market is paying for returns on equity rather than revenue scale.
Historical context is revealing: LPLA's own PE has ranged from roughly 11.8x (Q1 2023) to 27.4x (Q2 2025), and its PS ratio has ranged from about 4.3x (Q2 2026) to 8.1x (Q3 2022) on the historical ratios series — meaning the current 1.65x PS reading is far below its own multi-year band, while the 32.6x trailing PE sits above the historical range due to compressed trailing earnings. The stock is therefore cheap on sales and expensive on trailing earnings, a classic signature of a margin-transition story where the market is waiting to see whether sweep repricing and integration costs are temporary or structural.
PE
32.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 12x~30x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
15.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on cash generation and leverage. TTM free cash flow is -$1.05 billion, driven by a Q3 2025 operating cash outflow of -$1.73 billion tied to working capital and roughly $1.54 billion of acquisitions, while debt-to-equity is 1.36x and interest expense was $101.5 million in Q2 2026. Net margin of 5.08% and operating margin of 13.45% remain well below the 2022–2023 high-teens operating margins, and sweep revenue of $484.8 million is still the largest profit lever, creating concentration risk if repricing continues. Earnings volatility is elevated: Q3 2025 produced a -$29.5 million net loss from a $219 million other-expense charge, and Q2 2026 carried $282.5 million of net other expenses, so integration costs can obscure underlying performance.
Market and competitive risks include valuation compression and sector rotation. The trailing PE of 32.56x sits above the stock's historical range of 11.8x–27.4x, and the 5.26x P/B is a premium book multiple that assumes continued high ROE; if ROE of 16.15% slips, the book multiple could compress sharply. Beta of 0.538 provides some insulation from broad market selloffs, but it also explains why LPLA captured little of the S&P 500's +15.53% one-year gain, and relative strength of -19.27 points over one year shows the stock is out of favor. Competitive disruption from wirehouse retention programs and RIA custodian pricing pressure could slow advisor recruiting, while the recent JPMorgan Q3 earnings miss highlights that capital-markets peers face near-term caution.
A worst-case scenario would combine a permanent sweep-revenue reset, a failed acquisition integration that keeps free cash flow negative, and a credit-market tightening that raises refinancing costs on 1.36x debt-to-equity. In that chain, the stock would likely retest its 52-week low of $260.15, which is 19.0% below the current $320.96, and a break below the $302 support shelf would confirm the year-long downtrend. The maximum drawdown of 32.39% shows the stock has already fallen that far from a prior peak, so a realistic adverse case is a -19% to -32% loss, or roughly $218–$260 per share, with the analyst low target of $354 offering little downside protection because it sits above the current price.
FAQ
The most severe risk is financial: TTM free cash flow of -$1.05 billion and debt-to-equity of 1.36x leave little room for error if credit markets tighten or acquisition integration costs recur, as they did with the $219 million Q3 2025 charge. Second is company-specific margin risk: sweep revenue of $484.8 million remains the largest profit lever, and deliberate repricing has kept net margin at 5.08% and operating margin at 13.45%, below the 2022–2023 high-teens levels. Third is competitive risk from wirehouse retention programs and RIA custodian pricing pressure that could slow advisor recruiting and asset growth. Fourth is macro and market risk: beta of 0.538 limits volatility, but the stock has already suffered a 32.39% maximum drawdown and trades at 43.5% of its 52-week range, so a sector rotation away from capital-markets names could retest the $260.15 low.
The 12-month forecast has three scenarios: a base case with 50% probability targeting $354–$422, a bull case with 30% probability targeting $422–$554, and a bear case with 20% probability targeting $260–$302. The base case is most likely and assumes revenue growth stays in the high-20s to low-30s percent range while operating margin holds between 13% and 15%, with consensus EPS of $42.18 achieved. The bull case requires sweep-revenue stabilization and operating margin above 15%, while the bear case assumes a structural margin reset and a break below $302 support. The analyst average target of $422.38 sits at the top of the base-case range, consistent with the Buy consensus of 1.72.
The valuation is split: LPLA looks undervalued on sales at 1.65x PS and 1.60x EV/Sales, far below its historical PS band of roughly 4.3x–8.1x, but expensive on trailing earnings at 32.56x PE, above its historical range of 11.8x–27.4x. The forward PE of 10.63x versus trailing 32.56x implies the market expects a 67% earnings step-up to consensus EPS of $42.18, so the current price embeds optimism about margin recovery. The 5.26x P/B is a premium book multiple that assumes ROE of 16.15% persists. Overall, the market is paying a fair price on forward earnings and a discount on sales, but the valuation is not a clear bargain until free cash flow turns positive.
From a risk/reward perspective, LPLA offers 31.6% upside to the analyst average target of $422.38 against roughly 19% downside to the 52-week low of $260.15, a favorable but not exceptional ratio. The stock trades at 1.65x sales and 10.63x forward earnings, both undemanding relative to its 35.24% revenue growth, but negative TTM free cash flow of -$1.05 billion and a 13.45% operating margin below historical high-teens levels are real caveats. The biggest downside risk is a permanent sweep-revenue reset that keeps margins compressed and invalidates the forward EPS estimate. It is a good buy for medium-term investors who believe margins normalize and who can tolerate a stock that has lagged the S&P 500 by 19.27 points over one year; it is less suitable for those needing immediate cash flow or momentum.
LPLA is better suited to a medium-to-long-term holding period of at least 12–18 months, because the thesis depends on margin normalization and free cash flow recovery that will take several quarters to confirm. Beta of 0.538 and a 32.39% maximum drawdown mean short-term trading carries whipsaw risk, and the stock's -19.27 point relative underperformance over one year shows momentum is currently negative. The dividend yield of 0.34% and payout ratio of 10.94% provide negligible income, so returns must come from capital appreciation tied to the forward EPS of $42.18. A concrete minimum holding period is 12 months, ideally through the next two earnings reports, to see whether operating margin recovers above 15% and free cash flow turns positive.